NOVAworks

Novaworks is a South Korean biotechnology company specializing in AI-driven drug discovery and computational toxicology. The company leverages its proprietary in silico platforms, such as NovaTox and NovaLead, to predict the safety and efficacy of chemical compounds during the early stages of drug development. By integrating quantitative structure-activity relationship (QSAR) models and machine learning, Novaworks provides researchers with tools to reduce the time and cost associated with traditional laboratory testing. Their services are primarily utilized by pharmaceutical companies and regulatory agencies for toxicity assessment and lead optimization. The company plays a significant role in supporting regulatory compliance for chemical and pharmaceutical safety in the Asian market.